Recurrent Pregnancy Loss in Assam: Causes, Diagnosis & Treatment Options

Recurrent Pregnancy Loss (RPL) is one of the most emotionally and physically taxing conditions a couple can face. Medically, it is defined as two or more failed pregnancies before the fetus reaches viability — typically before 20 weeks, though many losses occur in the first trimester. In Assam, cultural silence around pregnancy loss means that many couples — particularly in smaller towns like Jorhat, Tezpur, and Nagaon — do not seek specialist evaluation after even a second or third loss.

Nationally, RPL affects roughly 1–2% of couples, but secondary RPL (occurring after at least one successful delivery) is also clinically significant and often overlooked. In Assam specifically, limited access to reproductive immunology and genetic counselling has historically meant that root causes go uninvestigated for years. Awareness is the first step toward a solution.

HomeIVF's tele-consultation model means that a couple in Dibrugarh or Silchar can now receive the same depth of RPL evaluation as someone walking into a Guwahati fertility clinic — without the travel burden, cost of repeated clinic visits, or time away from work. Understanding that RPL has identifiable causes in the majority of cases is itself a powerful, hope-restoring starting point.

RPL is rarely caused by a single factor. A thorough clinical workup typically reveals one or more of the following underlying causes, each of which has targeted treatment options.

**Chromosomal Abnormalities:** The most frequent cause, accounting for 50–60% of early losses. In most cases, these are sporadic embryonic errors rather than inherited parental chromosomal problems. However, parental karyotyping can identify balanced translocations that significantly increase loss risk and guide decisions around Preimplantation Genetic Testing (PGT-A) during IVF.

**Uterine Structural Anomalies:** Conditions such as a septate uterus, submucous fibroids, intrauterine adhesions (Asherman's syndrome), or a bicornuate uterus can physically prevent implantation or disrupt fetal development. These are commonly diagnosed via 3D ultrasound or hysteroscopy and are correctable with surgery.

**Antiphospholipid Syndrome (APS):** This autoimmune clotting disorder is found in 15–20% of RPL patients. APS causes micro-clots in placental blood vessels, starving the embryo of oxygen and nutrients. It is highly treatable with low-dose aspirin and low molecular weight heparin injections during pregnancy.

**Hormonal and Metabolic Factors:** Poorly controlled thyroid disorders (especially hypothyroidism, which is prevalent in Assam's iodine-deficient tea-belt regions), elevated prolactin, uncontrolled diabetes, and polycystic ovary syndrome (PCOS) all contribute meaningfully to RPL risk.

**Thrombophilias:** Inherited clotting disorders such as Factor V Leiden mutation or MTHFR gene variants impair placental circulation and are identified through specific blood panels.

**Unexplained RPL:** Even after a full workup, approximately 40–50% of cases remain unexplained. Emerging research into uterine natural killer cells, sperm DNA fragmentation, and endometrial receptivity is beginning to offer answers for this group.

The defining feature of RPL is a pattern — not a single loss. However, certain symptoms and circumstances should prompt earlier evaluation rather than waiting for a third miscarriage, which international guidelines now support.

Symptoms that accompany each pregnancy loss typically include vaginal bleeding (ranging from light spotting to heavy flow), cramping pelvic pain, and passage of tissue. What distinguishes RPL from a random loss is the recurrence of this pattern, often at similar gestational ages, suggesting a systemic rather than random cause.

In Assam, couples are advised to seek specialist evaluation after even a second consecutive loss, particularly if: the woman is over 35 years of age; there is a family history of clotting disorders or chromosomal conditions; losses occur consistently at the same gestational age (suggesting a structural or immunological cause); or if prior investigations at a local clinic in Guwahati or Silchar have been inconclusive.

HomeIVF's care coordinators in Assam are available for a free initial consultation to review your history and determine whether a full RPL workup is clinically indicated. Do not wait for a third loss — early investigation saves time, emotional energy, and in many cases, the next pregnancy.

A comprehensive RPL workup is the cornerstone of effective management. HomeIVF follows evidence-based international protocols — endorsed by the HomeIVF Medical Board — to ensure no cause is overlooked. The following investigations are typically ordered after a confirmed diagnosis of RPL.

**Genetic Testing:** Parental karyotyping (blood test for both partners) identifies balanced chromosomal translocations. Products of conception (POC) analysis on miscarried tissue identifies embryonic chromosomal errors and guides future treatment.

**Uterine Assessment:** 3D transvaginal ultrasound, saline infusion sonohysterography (SIS), or diagnostic hysteroscopy evaluate the uterine cavity for septa, fibroids, polyps, and adhesions. These can now be coordinated from Guwahati's network of HomeIVF-partnered diagnostic centres.

**Immunological and Thrombophilia Panel:** Anticardiolipin antibodies, lupus anticoagulant, beta-2 glycoprotein antibodies (for APS), Factor V Leiden, MTHFR mutations, Protein C and S levels.

**Hormonal Profile:** TSH, free T3/T4, prolactin, fasting insulin, HbA1c, AMH (ovarian reserve), and day 2–3 FSH/LH/estradiol.

**Sperm DNA Fragmentation Index (DFI):** Increasingly recognised as a contributor to RPL, elevated sperm DNA damage is assessed via the TUNEL or SCSA assay. Couples in Dibrugarh and Jorhat can have samples collected at partnered collection centres and processed centrally.

**Endometrial Receptivity Testing:** The ERA (Endometrial Receptivity Array) test identifies the precise implantation window, which may be displaced in some RPL patients.

Results are reviewed by the HomeIVF Medical Board and presented to you in a clear, actionable report within 7–10 working days.

Once a cause (or contributing causes) is identified, RPL treatment becomes targeted, logical, and — for most patients — genuinely hopeful. HomeIVF offers a full spectrum of RPL-specific treatments coordinated through its platform.

**Surgical Correction of Uterine Anomalies:** Hysteroscopic septum resection, polypectomy, myomectomy, or adhesiolysis significantly improves implantation and live birth rates in structurally compromised uteruses. HomeIVF coordinates pre- and post-operative care, including follow-up imaging.

**Anticoagulation Therapy for APS and Thrombophilias:** Low-dose aspirin (75–100 mg daily) combined with low molecular weight heparin (LMWH) injections significantly reduces pregnancy loss in APS patients. HomeIVF nurses can train patients in self-injection technique at home — an especially important feature for couples in smaller Assam towns where clinic access is limited.

**Thyroid and Hormonal Optimisation:** TSH is targeted to below 2.5 mIU/L before conception. Prolactin normalisation, insulin sensitisers for PCOS-related RPL (metformin under supervision), and progesterone supplementation in the luteal phase are all managed through HomeIVF's digital prescription and monitoring system.

**IVF with Preimplantation Genetic Testing (PGT-A/PGT-SR):** For couples with chromosomal causes of RPL or unexplained RPL after multiple failures, IVF combined with PGT-A (screening embryos for chromosomal normalcy before transfer) dramatically reduces miscarriage rates and improves live birth outcomes. HomeIVF manages this process end-to-end, from ovarian stimulation monitoring at home to coordinating the embryology and biopsy at a partnered lab.

**Sperm DNA Fragmentation Treatment:** Antioxidant therapy, lifestyle modification, and in some cases surgical sperm retrieval (if varicocele is causative) can reduce DFI and improve embryo quality.

**Unexplained RPL Protocols:** Emerging treatments including intralipid infusions, progesterone pessaries, and endometrial scratching are offered on a case-by-case basis, guided by the latest evidence reviewed by the HomeIVF Medical Board.

One of the most common barriers couples in Assam face is uncertainty about what RPL investigation and treatment will cost — and how long it will take. HomeIVF believes in transparent, structured care pathways.

A full RPL diagnostic workup — including genetic, immunological, hormonal, uterine, and sperm DNA testing — typically takes 3–6 weeks to complete, depending on which tests are needed and how quickly results are returned from laboratories. Most blood-based tests can be collected at HomeIVF-partnered phlebotomy centres in Guwahati, Dibrugarh, and Silchar, eliminating the need for long travel.

For couples who require IVF as part of their RPL treatment — particularly those pursuing PGT-A or those with multiple failed natural conceptions — HomeIVF offers comprehensive IVF packages starting from ₹1.5 lakh, with transparent breakdowns of what is included. This is significantly more accessible than the unstructured pricing common at standalone fertility clinics in Assam.

Timelines for treatment vary: hormonal optimisation and anticoagulation therapy can be initiated within days of diagnosis. Surgical correction of uterine anomalies typically requires a 4–8 week recovery window before the next conception attempt. IVF cycles generally run 3–5 weeks per cycle. HomeIVF's care team provides a personalised timeline roadmap at the outset of treatment, so couples always know what comes next and when.

Geography has long been one of the biggest barriers to quality fertility care in Assam. Couples from Tinsukia, Bongaigaon, or Karimganj have historically had to travel hours to Guwahati — sometimes repeatedly — for monitoring scans, blood draws, and medication adjustments during a treatment cycle. HomeIVF's model fundamentally changes this dynamic.

Through HomeIVF's platform, ovarian stimulation monitoring during an IVF cycle is coordinated through a network of partnered ultrasound centres and phlebotomy points across Assam. Results are uploaded digitally, reviewed by the HomeIVF Medical Board, and medication dosing is adjusted in real time — all without the patient needing to relocate or take repeated days off work.

HomeIVF-trained nurses visit patients at home for injections, sample collection, and medication guidance. This is not a compromise — it is senior-specialist care delivered at home, with the same protocols, the same quality standards, and the same level of medical oversight as a premium fertility clinic.

For RPL patients specifically, the psychological benefit of continuous, accessible support cannot be overstated. RPL carries a significant mental health burden — anxiety, grief, and anticipatory fear during subsequent pregnancies are well documented. HomeIVF's care model includes regular check-ins, prompt responses to patient queries, and emotional support coordination, which clinical evidence suggests itself improves outcomes.

Despite rising awareness of fertility treatments across India, several specific barriers make RPL care challenging in Assam. HomeIVF has designed its platform directly to address these.

**Limited Specialist Availability:** Reproductive medicine specialists with RPL expertise are concentrated in Guwahati, leaving couples in Silchar, Jorhat, Nagaon, and smaller districts without accessible expert care. HomeIVF's tele-consultation infrastructure connects all Assam patients to senior-specialist expertise regardless of their location.

**Diagnostic Infrastructure Gaps:** Advanced tests such as ERA, PGT-A, and sperm DNA fragmentation analysis require specialised labs not always available locally. HomeIVF coordinates sample logistics to partner labs across India with cold-chain pickup from Assam, ensuring no patient is disadvantaged by geography.

**Cultural and Language Barriers:** HomeIVF care coordinators in Assam are trained to communicate sensitively and, where possible, in Assamese — ensuring that medical information is understood, not just heard.

**Financial Uncertainty:** Transparent package pricing and EMI options make care accessible to middle-income families across Assam who might otherwise spend equivalent sums on unstructured, piecemeal investigations at multiple facilities without a clear plan.

**Emotional Isolation:** RPL can be profoundly isolating, particularly in communities where pregnancy loss is not openly discussed. HomeIVF's patient community and counselling resources offer a safe, private space for couples navigating this journey.

The HomeIVF Medical Board reviews every RPL case to ensure the highest standard of evidence-based care — no matter where in Assam a patient is located.